MCQOPTIONS
Saved Bookmarks
| 1. |
In December 2020, which company has partnered with Russia’s Gamaleya Research Institute, (RDIF) and R-Pharm to assess the safety and immunogenicity of a combination of their respective adenovirus-vector vaccines AZD1222 and Sputnik V? |
| A. | bharat biotech |
| B. | AstraZeneca |
| C. | Biocon |
| D. | Syngene International Limited |
| E. | Cadila Healthcare |
| Answer» C. Biocon | |